These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9110291)

  • 1. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
    Prayson RA
    Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
    Miyagami M; Nakamura S
    No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
    Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
    Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
    Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
    Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
    Gyure KA; Prayson RA
    Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery.
    Sakai Y; Matsuyama Y; Katayama Y; Imagama S; Ito Z; Wakao N; Kanemura T; Yoshida G; Sato K; Ando T; Nakamura H; Kato F; Yukawa Y; Ito K; Ishiguro N
    Spine (Phila Pa 1976); 2009 Jul; 34(15):1619-24. PubMed ID: 19564773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic pleomorphic xanthoastrocytoma.
    Prayson RA; Morris HH
    Arch Pathol Lab Med; 1998 Dec; 122(12):1082-6. PubMed ID: 9870856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
    Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
    Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina.
    Nakamura M; Ishii K; Watanabe K; Tsuji T; Matsumoto M; Toyama Y; Chiba K
    Spine (Phila Pa 1976); 2009 Oct; 34(21):E756-60. PubMed ID: 19934795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic results of eight patients with intracranial ependymomas].
    Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
    No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord.
    Iwata K; Nakagawa H; Hashizume Y
    Noshuyo Byori; 1996 Apr; 13(1):73-8. PubMed ID: 8916130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms.
    Prayson RA; Suh JH
    Arch Pathol Lab Med; 1999 Apr; 123(4):306-9. PubMed ID: 10320142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.
    Fetsch JF; Laskin WB; Hallman JR; Lupton GP; Miettinen M
    Am J Surg Pathol; 2007 Jul; 31(7):1103-14. PubMed ID: 17592278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
    Machen SK; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.